Mj. Callow et al., EXPRESSION OF HUMAN APOLIPOPROTEIN-B AND ASSEMBLY OF LIPOPROTEIN(A) IN TRANSGENIC MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2130-2134
The atherogenic macromolecule lipoprotein(a) [Lp(a)] has resisted in v
ivo analyses partly because it is found in a limited number of experim
ental animals. Although transgenic mice expressing human apolipoprotei
n (a) [apo(a)l have previously been described, they failed to assemble
Lp(a) particles because of the inability of human apo(a) to associate
with mouse apolipoprotein B (apoB). We isolated a 90-kilobase P1 phag
emid containing the human apoB gene and with this DNA generated 13 lin
es of transgenic mice of which 11 expressed human apoB. The human apoB
transcript was expressed and edited in the liver of the transgenic mi
ce. Plasma concentrations of human apoB, as well as low density lipopr
otein (LDL), were related to transgene copy number; the transgenic lin
e with the most copies of human apoB had a >4-fold increase in LDL cho
lesterol compared with nontransgenics and a lipoprotein profile simila
r to that of humans. When human apoB and apo(a) transgenic mice were b
red together, plasma apo(a) in mice expressing both human proteins was
tightly associated with lipoproteins in the LDL density region. These
studies demonstrate the successful expression of human apoB and the e
fficient assembly of Lp(a) in mice.